Skip to main content
S 977 116th Congress Senate Health Asia Canada Consumer affairs Employee benefits and pensions Europe France Germany Health care costs and insurance Health care coverage and access Inflation and prices Japan Prescription drugs Retail and wholesale trades United Kingdom

Transparent Drug Pricing Act of 2019

Introduced: April 1, 2019 Introduced by: Scott, Rick Republican · Florida See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 1, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Apr 1, 2019
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Transparent Drug Pricing Act of 2019

This bill establishes several requirements relating to the prices of prescription drugs.

For example, state Medicaid drug-use review programs must require pharmacists to disclose an individual's out-of-pocket cost for a prescription drug, and the price without health insurance, at the point-of-sale. Additionally, health insurers must publish the co-payment amount for each covered prescription drug prior to the annual open-enrollment period.

The bill also temporarily prohibits the retail list price of drugs and biologics from exceeding the lowest retail list price among Canada, France, the United Kingdom, Japan, or Germany.

What's happening now April 1, 2019

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1
R
Hawley, Josh
Missouri · Apr 1, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). S. 977: Transparent Drug Pricing Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-S-977/
MLA
"S. 977: Transparent Drug Pricing Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-977/.
Bluebook (legal)
S. 977, 116th Cong. (2026), https://openamerica.io/bill/116-S-977/.
Markdown link
[S. 977: Transparent Drug Pricing Act of 2019](https://openamerica.io/bill/116-S-977/)
Report a problem